NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) is set to host an exclusive R&D day at the Lotte New York Palace Hotel on June 11, 2024, at 10:00 AM ET. The event will spotlight the company’s pioneering atrioventricular interval modulation (AVIM) therapy, with insights from top medical experts and company management.
Esteemed speakers include David Kandzari, M.D., of Piedmont Heart Institute and Vivek Reddy, M.D., from Mount Sinai Hospital, both of whom have played significant roles in the development and study of AVIM therapy through the BACKBEAT global pivotal study.
Attendees will gain an in-depth understanding of the unmet needs in treatment for pacemaker-indicated patients with uncontrolled hypertension, the mechanics behind AVIM therapy, and a comprehensive overview of clinical evidence supporting its efficacy. The day will conclude with a live Q&A session, allowing for direct interaction with the experts.
This gathering promises to shed light on Orchestra BioMed’s lead program and its potential to revolutionize care for patients with hypertension.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and Microsoft Start.